1: Graillon T, Boissonneau S, Appay R, Boucekine M, Peyrière H, Meyer M, Farah K, Albarel F, Morange I, Castinetti F, Brue T, Fuentes S, Figarella-Branger D, Cuny T, Dufour H. Meningiomas in patients with long-term exposition to progestins: Characteristics and outcome. Neurochirurgie. 2021 May 11:S0028-3770(21)00145-4. doi: 10.1016/j.neuchi.2021.04.018. Epub ahead of print. PMID: 33989642.

2: AbiJaoude S, Marijon P, Roblot P, Tran S, Cornu P, Kalamarides M, Peyre M. Sustained growth of intraosseous hormone-associated meningiomas after cessation of progestin therapy. Acta Neurochir (Wien). 2021 Jun;163(6):1705-1710. doi: 10.1007/s00701-021-04781-8. Epub 2021 Mar 2. PMID: 33649877.

3: Malaize H, Samoyeau T, Zanello M, Roux A, Benzakoun J, Peeters S, Zah-Bi G, Edjlali M, Tauziede-Espariat A, Dezamis E, Parraga E, Chrétien F, Varlet P, Plu- Bureau G, Oppenheim C, Pallud J. Evolution of the neurosurgical management of progestin-associated meningiomas: a 23-year single-center experience. J Neurooncol. 2021 Apr;152(2):279-288. doi: 10.1007/s11060-021-03696-9. Epub 2021 Jan 15. PMID: 33449307.

4: Apra C, Roblot P, Alkhayri A, Le Guérinel C, Polivka M, Chauvet D. Female gender and exogenous progesterone exposition as risk factors for spheno-orbital meningiomas. J Neurooncol. 2020 Aug;149(1):95-101. doi: 10.1007/s11060-020-03576-8. Epub 2020 Jul 23. PMID: 32705456.

5: Passeri T, Champagne PO, Bernat AL, Hanakita S, Salle H, Mandonnet E, Froelich S. Spontaneous regression of meningiomas after interruption of nomegestrol acetate: a series of three patients. Acta Neurochir (Wien). 2019 Apr;161(4):761-765. doi: 10.1007/s00701-019-03848-x. Epub 2019 Feb 19. PMID: 30783806.

6: Champagne PO, Passeri T, Froelich S. Combined hormonal influence of cyproterone acetate and nomegestrol acetate on meningioma: a case report. Acta Neurochir (Wien). 2019 Mar;161(3):589-592. doi: 10.1007/s00701-018-03782-4. Epub 2019 Jan 22. PMID: 30666456.